Compound ID | 743
FMA 0713
Class: Macrolide (14-membered macrolide)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Protein synthesis inhibitor. FMA 0713 demonstrated strong activity against erythromycin A susceptible and resistant S. pneumoniae, S. pyogenes and Staphylococcus aureus |
| Institute where first reported: | Taisho Pharmaceuticals |
| Year first mentioned: | 1999 |
| Highest developmental phase: | Preclinical |
| Development status: | Discontinued |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.